| scholarly article | Q13442814 |
| P356 | DOI | 10.1212/WNL.57.8.1392 |
| P698 | PubMed publication ID | 11673578 |
| P2093 | author name string | Khan H | |
| Jankovic J | |||
| Ondo WG | |||
| Kwak C | |||
| Dat Vuong K | |||
| Atassi F | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 1392-1396 | |
| P577 | publication date | 2001-10-01 | |
| P1433 | published in | Neurology | Q1161692 |
| P1476 | title | Daytime sleepiness and other sleep disorders in Parkinson's disease | |
| P478 | volume | 57 |
| Q34716838 | 'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect? |
| Q48467673 | A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France |
| Q28256463 | A reassessment of risks and benefits of dopamine agonists in Parkinson's disease |
| Q38662579 | A review of adverse events linked to dopamine agonists in the treatment of Parkinson's disease |
| Q34703509 | Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer's disease using the Multiple Sleep Latency Test |
| Q43175529 | Activity-rest rhythm abnormalities in Parkinson's disease patients are related to dopaminergic therapy |
| Q37527782 | Anatomy of disturbed sleep in pallido-ponto-nigral degeneration |
| Q33820609 | Behavioral phenotyping of mouse models of Parkinson's disease |
| Q35103955 | Brainstem: neglected locus in neurodegenerative diseases. |
| Q35751844 | Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough |
| Q36882599 | Circadian and sleep disorders in Parkinson's disease |
| Q33835856 | Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease |
| Q40324460 | Clinical characteristics of sleep disorders in patients with Parkinson's disease |
| Q34440705 | Cul3 and the BTB adaptor insomniac are key regulators of sleep homeostasis and a dopamine arousal pathway in Drosophila |
| Q36876438 | Current approaches to the treatment of Parkinson's disease |
| Q48213412 | Daytime course of sleepiness in de novo Parkinson's disease patients |
| Q34150079 | Daytime sleepiness in Parkinson's disease: a reappraisal |
| Q41946113 | Daytime sleepiness in Parkinson's disease: perception, influence of drugs, and mood disorder |
| Q37170504 | Daytime sleepiness is associated with falls in Parkinson's disease |
| Q64786322 | Daytime sleepiness may be an independent symptom unrelated to sleep quality in Parkinson's disease |
| Q28386242 | Development of the National Healthy Sleep Awareness Project Sleep Health Surveillance Questions |
| Q37060398 | Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease |
| Q35035753 | Distinguishing between excessive daytime sleepiness and fatigue: toward improved detection and treatment |
| Q35570952 | Dopamine agonists in Parkinson’s disease |
| Q37685661 | Dopamine receptor agonists and sleep disturbances in Parkinson's disease |
| Q48561634 | Driving in Parkinson's disease: mobility, accidents, and sudden onset of sleep at the wheel |
| Q38051969 | Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia |
| Q48498835 | Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study |
| Q37116481 | Evaluating daytime alertness in individuals with Restless Legs Syndrome (RLS) compared to sleep restricted controls |
| Q38886330 | Excessive Daytime Sleepiness Predicts Neurodegeneration in Idiopathic REM Sleep Behavior Disorder |
| Q52583507 | Excessive Daytime Sleepiness in Parkinson's Disease: Clinical Implications and Management. |
| Q35211225 | Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease |
| Q36415820 | Excessive daytime sleepiness and unintended sleep in Parkinson's disease |
| Q37842431 | Excessive daytime sleepiness in patients with Parkinson's disease |
| Q48497382 | Excessive daytime sleepiness in patients with Parkinson's disease: a polysomnography study |
| Q64867863 | Excessive daytime sleepiness, objective napping and 11-year risk of Parkinson's disease in older men |
| Q44992352 | Excessive daytime somnolence in Japanese patients with Parkinson's disease |
| Q80153768 | Excessive sleepiness in Parkinson's disease: a wake-up call |
| Q43057272 | Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment |
| Q36667874 | Fatigue in Parkinson's disease: a review |
| Q48264764 | Gender-related differences in the burden of non-motor symptoms in Parkinson's disease |
| Q37687264 | Healthcare providers' knowledge of disordered sleep, sleep assessment tools, and nonpharmacological sleep interventions for persons living with dementia: a national survey. |
| Q37718036 | How vital is sleep in Huntington's disease? |
| Q44351580 | Increased daytime sleepiness in Parkinson's disease: a questionnaire survey |
| Q37112212 | Insomnia in patients with neurodegenerative conditions. |
| Q46134615 | Levodopa use and sleep in patients with dementia with Lewy bodies. |
| Q45279293 | Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial |
| Q39100264 | Management of sleep disorders in Parkinson's disease and multiple system atrophy |
| Q36847271 | Management of the behavioral aspects of Parkinson's disease |
| Q43258448 | Modafinil for Parkinson's disease fatigue |
| Q35485478 | Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial |
| Q48614304 | Modulation of normal and pathologic motoneuron activity during sleep: insights from the neurology clinic, Parkinson's disease, and comments on parkinsonian-related sleepiness |
| Q38663680 | Mood and neural correlates of excessive daytime sleepiness in Parkinson's disease |
| Q33854899 | Motor and Non-Motor Symptoms in Parkinson's Disease: Effects on Quality of Life |
| Q40911752 | Multimodal imaging evaluation of excessive daytime sleepiness in Parkinson's disease |
| Q57173227 | NREM sleep parasomnias as disorders of sleep-state dissociation |
| Q48479809 | Nature and variants of idiopathic restless legs syndrome: observations from 152 patients referred to secondary care in the UK. |
| Q57493665 | Neuroimaging of Sleep Disturbances in Movement Disorders |
| Q35540910 | Nocturnal symptom complex in PD and its management |
| Q36525764 | Non-motor aspects of Parkinson's disease. |
| Q37825377 | Nonmotor disturbances in Parkinson's disease |
| Q48423467 | Obstructive sleep apnoea-hypopnoea syndrome presenting in the neurology clinic: a prospective 5-year study |
| Q46544628 | Open-label pilot study of levetiracetam (Keppra) for the treatment of levodopa-induced dyskinesias in Parkinson's disease |
| Q38123748 | Parkinson disease and sleep: sleep-wake changes in the premotor stage of Parkinson disease; impaired olfaction and other prodromal features |
| Q80319319 | Parkinson disease: an update |
| Q38357853 | Parkinson's disease and sleep/wake disturbances |
| Q47761295 | Parkinsonism and vigilance: alteration in neural oscillatory activity and phase-amplitude coupling in the basal ganglia and motor cortex |
| Q48561446 | Parkinsonism with excessive daytime sleepiness--a narcolepsy-like disorder? |
| Q28074765 | Physicians' role in the determination of fitness to drive in patients with Parkinson's disease: systematic review of the assessment tools and a call for national guidelines |
| Q35141391 | Physiological and anatomical link between Parkinson-like disease and REM sleep behavior disorder |
| Q44316809 | Piribedil-induced sleep attacks in Parkinson's disease |
| Q36407375 | Pramipexole for the treatment of restless legs syndrome |
| Q46784640 | Pramipexole safely replaces ergot dopamine agonists with either rapid or slow switching |
| Q45076628 | Predictors of sudden onset of sleep in Parkinson's disease |
| Q46460304 | Prescribing pattern in Parkinson's disease: are cost and efficacy overriding factors? |
| Q39344081 | Prevalence of nocturia in Parkinson's disease patients from various ethnicities. |
| Q92786736 | Prevalence of sleep disorders in Parkinson's disease patients in two neurology referral hospitals in Ethiopia |
| Q35059012 | Probable RBD is increased in Parkinson's disease but not in essential tremor or restless legs syndrome |
| Q49885719 | Quality of Sleep and Sleep Disorders in Patients with Parkinsonism: A Polysomnography Based Study from Rural South India |
| Q36477085 | REM sleep behavior disorder in Parkinson's disease: a questionnaire-based survey |
| Q35110581 | REM sleep behavior disorder in the marmoset MPTP model of early Parkinson disease |
| Q38206387 | Rating scales and questionnaires for assessment of sleep disorders in Parkinson's disease: what they inform about? |
| Q36297809 | Recognition and diagnosis of sleep disorders in Parkinson's disease |
| Q48544098 | Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease |
| Q34617020 | Relationships among cognitive impairment, sleep, and fatigue in Parkinson's disease using the MDS-UPDRS |
| Q48614297 | Restless legs syndrome (RLS), Parkinson's disease, and sustained dopaminergic therapy for RLS |
| Q37166108 | Ropinirole for the treatment of restless legs syndrome |
| Q36106752 | Ropinirole in the treatment of restless legs syndrome |
| Q37798777 | Scales to assess sleep impairment in Parkinson's disease: critique and recommendations |
| Q64119432 | Sleep Disorders in Huntington's Disease |
| Q91893844 | Sleep Disorders in Rodent Models of Parkinson's Disease |
| Q52142287 | Sleep Dysfunction in Parkinson's Disease. |
| Q45252416 | Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment |
| Q35140357 | Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known? |
| Q44316812 | Sleep attacks in Parkinson's disease induced by Entacapone, a COMT-inhibitor |
| Q44817248 | Sleep disorders and parkinsonian syndromes |
| Q84867175 | Sleep disorders in Parkinson's disease |
| Q37923780 | Sleep disturbances associated with Parkinson's disease |
| Q37681251 | Sleep disturbances in Parkinson disease and their potential role in heterogeneity |
| Q35065238 | Sleep disturbances in Parkinson's disease |
| Q83053586 | Sleep disturbances in Parkinson's disease |
| Q42655947 | Sleep disturbances in Taiwanese patients with Parkinson's disease. |
| Q37132724 | Sleep disturbances in patients with parkinsonism |
| Q44499646 | Sleep disturbances in untreated Parkinson's disease. |
| Q48422836 | Sleep in Parkinson syndromes |
| Q36233214 | Sleep in aging and neurodegenerative diseases. |
| Q46836591 | Sleep problems and hypothalamic dopamine D3 receptor availability in Parkinson disease |
| Q36459932 | Sleep-related problems of Parkinson's disease |
| Q46006501 | Sleep-wake cycle and effects of cabergoline monotherapy in de novo Parkinson's disease patients. An ambulatory polysomnographic study. |
| Q38214475 | Sleep/wake problems in Parkinson's disease: pathophysiology and clinicopathologic correlations |
| Q41675120 | Sleepiness and Depression in Parkinson's Disease Patients Treated with Ropinirole and Levodopa. |
| Q48632030 | Sleepiness and Unintended Sleep in Parkinson's Disease |
| Q36076655 | Sleepiness in Idiopathic REM Sleep Behavior Disorder and Parkinson Disease |
| Q43190971 | Sleepiness in Parkinson's disease |
| Q48626650 | Sleepiness in Parkinson's disease: a controlled study |
| Q48318293 | Sleepwalking in Parkinson's disease: a questionnaire-based survey |
| Q44049630 | Sleepwalking, REM sleep behaviour disorder and overlap parasomnia in patients with Parkinson's disease |
| Q45987982 | Slow wave sleep and dopaminergic treatment in Parkinson's disease: a polysomnographic study. |
| Q48485654 | Subjectively reported sleep quality and excessive daytime somnolence in Parkinson's disease with and without dementia, dementia with Lewy bodies and Alzheimer's disease |
| Q35560075 | The Parkinson's disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson's disease |
| Q90625132 | The Parkinson's progression markers initiative (PPMI) - establishing a PD biomarker cohort |
| Q35015809 | The basis for day and night-time control of symptoms of Parkinson's disease |
| Q37699207 | The nonmotor symptoms of Parkinson's disease--an overview |
| Q48686419 | The relation of falls to fatigue, depression and daytime sleepiness in Parkinson's disease |
| Q35189103 | Toward a molecular neuropsychiatry of neurodegenerative diseases |
| Q41843365 | Traditional chinese medicine improves activities of daily living in Parkinson's disease |
| Q34581494 | Treating restless legs syndrome: current pathophysiological concepts and clinical trials |
| Q38913876 | Treatment of Sleep Disorders in Dementia |
| Q36562673 | Visual and cognitive predictors of driving safety in Parkinson's disease patients |
| Q37874195 | When Parkinson's disease patients go to sleep: specific sleep disturbances related to Parkinson's disease |
| Q48944618 | Widespread cortical and subcortical brain atrophy in Parkinson's disease with excessive daytime sleepiness. |
| Q88019223 | [Nonmotor symptoms in Parkinson's disease] |
Search more.